19th March 2024

Whilst in neurology clinic you review a 27 year old male patient with relapsing-remitting multiple sclerosis (MS)

Whilst in neurology clinic you review a 27 year old male patient with relapsing-remitting multiple sclerosis (MS) whom has experienced frequent and debilitating flares despite disease modifying therapies. He has spoken to the MS nurses about possible therapies and would like to know more about Natalizumab however, he has read about some adverse events. Which serious adverse event may this patient be concerned about associated with natalizumab?

Select the SINGLE most appropriate option from the list below. Select ONE option only.